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Abstract: Currently, researchers and clinicians lack achromatized 
endomicroscope objectives that are as narrow as biopsy needles. We present 
a proof-of-concept prototype that validates the optical design of an NA0.4 
objective. The objective, built with plastic lenses, has a 0.9 mm clear 
aperture and is achromatized from 452 nm to 623 nm. The objective’s 
measured Strehl ratio is 0.74 ± 0.05 across a 250 μm FOV. We perform 
optical sectioning via structured illumination through the objective while 
capturing fluorescence images of breast carcinoma cells stained with 
proflavine and cresyl violet. This technology has the potential to improve 
optical biopsies and provide the next step forward in cancer diagnostics. 
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1. Introduction 
Breast cancer is a disease that will affect one in eight women in America during their lifetime 
[1]. When a suspicious region of the breast is identified during screening, usually via 
mammogram or clinical breast exam, a diagnosis is needed. Diagnoses typically require 
removing tissue samples or cells via invasive biopsy before a pathologist examines them with 
a bench top microscope. Cellular organization and nuclear size and shape are used to identify 
benign tissue, carcinoma in situ, invasive cancer, and other types of tissue, including 
inflammation and atypical hyperplasia [2,3]. A potential alternative to conventional biopsies 
is an “optical biopsy,” which uses a needle-sized endomicroscope to provide real-time, in vivo 
microscopy images without tissue removal. The endomicroscope can pierce the tissue to the 
region of interest, like a conventional biopsy needle, and then relay microscopic images out of 
the patient, allowing a mid-biopsy diagnosis. Optical biopsies should provide similar results 
to the current gold standard for diagnosis: conventional biopsy followed by H&E histology 
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staining. Therefore, endomicroscopes should have sub-cellular resolution, optical sectioning 
capability, and the ability to image multiple dyes simultaneously. We are developing an 
endomicroscope objective that fulfills these three conditions. 
Current endomicroscopes may use a fiber bundle, also called an image guide, to relay light 
from the region of interest to the imaging system without using an objective at the distal tip. A 
high-resolution microendoscope (HRME) has successfully imaged subcellular features and 
tissue organization in the oral cavity using a probe approximately 1 mm wide [4–6]. Because 
the outer diameter (OD) of core biopsies needles is 0.9 mm to 2.1 mm, this endomicroscope is 
narrow enough to perform an optical biopsy. After staining the tissue with proflavine, a 
fluorescent dye, the HRME displays the nuclei in the oral cavity as bright ovals. However, 
although the nuclei can be seen with the HRME, they cannot be sufficiently resolved, 
particularly in breast tissue. The nuclear diameter is approximately 5-10 μm, while the current 
resolution of the HRME is 8 μm, due to the fibers’ core-to-core spacing of 4 μm. Landau et al. 
[7] added a 3.2X objective to the tip of the same coherent fiber bundle, providing a resolution 
of 2.5 μm. A system with higher resolution would improve clinicians’ ability to identify 
cellular atypia, the absence of a myoepithelial cell layer, and invasion of cancer cells into 
normal tissue, all of which indicate malignancy [8]. This objective, like the one reported by 
Landau et al. [7], will help achieve this higher resolution. 
Some endomicroscopes use gradient index (GRIN) lenses as objectives at their distal tip. 
GRIN lenses are glass cylinders with a quadratically varying index of refraction along their 
radius. They suffer from strong spherical and chromatic aberrations [9–12]. When combined 
with a refractive glass lens, GRIN lenses can form objectives with limited monochromatic 
aberration correction and increased NA [13] while maintaining outer diameters as small as or 
smaller than a biopsy needle [14–16]. However, without axial chromatic aberration correction 
in the imaging system, dyes with different emission spectra cannot be imaged without one or 
more appearing blurred. 
Other miniature objectives utilizing conventional refractive lenses have also been 
designed and tested [17–24]. In all cases, the OD of the objective was significantly larger than 
the OD of a core biopsy needle (their diameters were between 2.6 mm and 7 mm) or the 
objective was designed for a single wavelength. Although others have recognized the 
advantages offered by plastic lenses and proposed achromatized systems [25,26], no one has 
yet constructed such devices, to the best of our knowledge. Our plastic lens objective is 
achromatized and the clear aperture is 0.9 mm, which can allow the distal optics to remain as 
narrow as a biopsy needle. 
To perform in vivo optical biopsies of thick tissue with high contrast images, optical 
sectioning is required to image a thin tissue slice and reject background light. Optical 
sectioning can be achieved via confocal, structured illumination, or multiphoton fluorescence 
imaging. The achromatic objective we are developing will be part of an endomicroscope 
which utilizes structured illumination, similar to that reported by Bozinovic et al. [27]. 
Recently, several papers showed the promising trend of mimicking H&E staining by 
creating pseudocolor images of excised tissue captured with fluorescence and reflectance 
confocal microscopy [28,29]. Göbel et al. also presented an optical biopsy system utilizing a 
fiber bundle without a distal objective which is capable of capturing in vivo fluorescence 
images of endogenous and exogenous sources [30]. Such images may help in pathological 
assessment. In the future, we will pursue real-time in vivo pseudocolor imaging of breast 
tissue by using multiple fluorescent dyes which target the nucleus and the cytoplasm. To 
perform this imaging in vivo, we require an endomicroscope utilizing an achromatized 
objective lens. 
In this study, we present a prototype which validates the optical design of an achromatized 
objective. The proof-of-concept demonstrates the ability to create an achromatized objective 
composed only of plastic lenses with a clear aperture of 0.9 mm and NA = 0.4. Although the 
current prototype is built in large discs, future iterations may be integrated into hypodermic 
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tubes, using previously described techniques [17,31], and then incorporated into 
endomicroscopes. 
2. Design 
The ultra-slim, all-plastic objective has been designed to achieve diffraction limited 
performance across a 171 nm wavelength range within the visible spectrum following the 
specifications listed in Table 1. The objective is particularly designed to work with two 
fluorescent dyes, proflavine and cresyl violet, which inherently stain the nucleus and 
cytoplasm, respectively. Proflavine has excitation and emission peaks at 452 nm and 515 nm. 
Cresyl violet has excitation and emission peaks at 575 nm and 623 nm. 
Table 1. Achromatic ultra-slim objective design specifications 
Object Space NAa 0.4 
Image Space NA 0.14 
Field of View (FOV) 250 μm 
Clear Aperture 0.9 mm 
Magnification −2.88 
Working Distancea 15 μm 
Wavelength Range 452-623 nm 
Telecentricity Object Space 
aObject space is intended for water immersion. 
At the center wavelength of 538 nm, an NA0.4 objective provides a diffraction limited 
resolution of 0.82 μm. A 0.9 mm clear aperture will allow the objective to be integrated with 
an endomicroscope to perform optical biopsies. The magnification matches the 250 μm FOV 
to the 720 μm imaging area of the endomicroscope’s fiber bundle. The short, 15 μm working 
distance allows the objective to image tissue while in direct contact. This distance can be 
increased for different applications by re-optimizing the design; for instance, our NA0.4 ultra-
slim objective for non-linear imaging has a working distance of 200 μm [31]. Telecentricity is 
maintained in object space. We previously reported that achieving image space telecentricity 
would mean compromising transverse magnification and performance at the edge of the 
image [7]. To counteract this effect, the principal ray angle was allowed to deviate from 0°. 
The analysis shows that, while this created some vignetting, the image quality is higher than if 
the design were strictly image space telecentric. 
The justification for using plastic as a lens material, particularly during fluorescence 
imaging, has already been detailed [31,32]. To summarize, the first and last lenses are 
composed of Zeonex E48R due to its crown-like optical properties and very low water 
absorption. Both doublets are made of PMMA, NOA61, and polystyrene. PMMA is a crown-
like plastic while polystyrene behaves like a flint, allowing achromatization. The plastics have 
high transmission and negligible autofluorescence across the design wavelength range. 
Creating aspheres in plastic lenses is no different from creating spheric surfaces, allowing 
simpler, cheaper designs using fewer components than glass. 
A lens prescription meeting the design requirements was developed in Zemax and is listed 
in Table 2. The objective design layout is illustrated in Fig. 1 and the nominal performance is 
shown in Fig. 2. Figure 2(a) plots the polychromatic MTF of the achromatic objective; it has 
diffraction limited performance except for the sagittal ray at edge of the FOV for 
polychromatic light. Figure 2(b) shows the image space chromatic focal shift; the maximum 
shift, 3.2 μm, is much shorter than the diffraction limited range of 22.0 μm. For this particular 
lens system, the expected transmission efficiency based on the Fresnel equations and the 
transmission rates measured in Kyrish et al. [31] is 58%; however, Tkaczyk et al. [33] created 
a significant improvement in their microscope’s throughput by adding AR coatings to the 
plastic lenses. This procedure can be used in future implementations to improve the 
transmission efficiency of the achromatic objective. 
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Table 2. Lens prescription of the achromatic objective 
Notes Radius (mm) Thickness (mm) Glass 4th Order  Aspheric Term 
6th Order  
Aspheric Term 
8th Order  
Aspheric Term 
Object 1.50000 0.046 Seawater    Lens 1 −0.29789 1.000 E48R    
 −0.62850 0.025     Lens 2 1.13232 1.070 PMMA −0.095743 0.579417 −1.044467 
 −0.59716 0.050 NOA61    Lens 3 −0.54874 1.000 Polystyrene    
 −2.26094 0.000  −0.093718 0.831976 −3.102985 Stop Infinity 0.050     Lens 4 1.35360 1.080 PMMA −0.048849 −0.026626  
 −0.78475 0.050 NOA61    Lens 5 −0.79370 2.012 Polystyrene    
 −1.00743 0.025  0.392702 −0.165720 0.183568 Lens 6 −2.31762 1.000 E48R    
 1.16361 0.286  −0.860845   Image Infinity      
 
Fig. 1. Schematic representation of the achromatic objective. The diameter of the lenses is 0.9 
mm. 
 
Fig. 2. Nominal performance of the achromatic objective. (a) Diffraction limited polychromatic 
MTF. (b) Diffraction limited image space chromatic focal shift. 
A thorough tolerancing of the design was also performed in Zemax. The tolerances listed 
in Table 3 are based on in-house fabrication capabilities. The lenses were formed via single 
point diamond turning (SPDT) using an ultra-precision lathe. Injection molding can be used to 
mass produce the lenses; for injection molding, the tolerances are considered commercial or 
state-of-the-art [34]. 
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Table 3. Tolerancing of the achromatic objective 
Tolerand Value 
Radius of curvature (%) ±1 
Thickness (μm) ±20 
Element decenter (μm) ±10 
Element tilt (°) ±0.15 
Doublet decenter (μm) ±15 
Doublet tilt (°) ±0.2 
Surface irregularity (fringes) ±1 
Index (%) ±1 
Abbe Number (%) ±1 
3. Fabrication and assembly 
A design proof-of-principle prototype of the ultra-slim achromatic objective was built in 22 
mm diameter plastic disks; while too large to be used in an endomicroscope, this allows the 
optical design to be validated. The fabrication process is similar to that described by McCall 
et al. [32]; using SPDT, the optical surfaces and the optomechanics were cut into the plastic 
disks, creating positive and negative alignment features in the same material as the lenses. 
Using the ultra-precision lathe to simultaneously create the optics and the mechanics 
maintains tight tolerances for radius, thickness, decentration, tilt, and surface irregularity. The 
objective was modeled in SolidWorks; a cutaway view is shown in Fig. 3(a). The positive 
annular features on the bottom of each lens are designed to be concentric with the negative 
triangular features of the following lens at two points. Blue permanent marker is added 5 mm 
away from the optical axis up to the edge of the clear aperture of each optical surface, creating 
baffles within the objective. These baffles reduce stray light, maintaining high contrast. 
Cemented doublets are held together by applying NOA61 directly to the concave optical 
surface. The lenses are stacked, two at a time, while mating the positive and negative 
alignment features. This procedure centers the lenses and ensures the designed spacing within 
the optical system. The adhesive is then cured with ultraviolet light. For the remaining lenses, 
a small amount of glue is added to the grooves and the edge of the discs before stacking the 
components. Figure 3(b) shows lenses 2 and 3 from Fig. 1 next to a US quarter. Figure 3(c) 
presents a fully assembled achromatic objective. In the future, this design will be built within 
a 1.4 mm OD hypodermic tube, as we have demonstrated before [31]. 
 
Fig. 3. (a) SolidWorks cutaway of the assembled achromatic objective with built-in alignment 
features used to validate the optical design. The insets show optical surfaces (left) and 
alignment features (right). (b) Example of two singlet lenses next to a US quarter with the clear 
apertures of the lenses circled. (c) Fully assembled prototype achromatic objective. 
4. Characterization and testing 
The functionality and performance of the achromatic objective were thoroughly characterized. 
First, doublet lenses were cut and assembled in order to measure their tilt and decentration. 
Next, the lateral performance and chromatic focal shift of a fully assembled objective were 
measured. Finally, the objective was used to image breast carcinoma cells which were stained 
with multiple fluorescent dyes. In order to demonstrate the limitations of a monochromatic 
objective and the need for achromatization, the chromatic focal shift measurement and 
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fluorescence imaging were also performed on a monochromatic objective prototype 
previously described by Landau et al. [7]. 
Copies of lens 2 and lens 3 (Fig. 3(b)) were fabricated and assembled to measure the tilt 
and decentration of the doublets. The doublet’s tilt was measured with a NewView 5020 
white light interferometer (Zygo). The doublet was placed on a microscope slide with its tilt 
reduced to less than 0.007° by adjusting the tilt of the interferometer’s stage until the total 
runout was less than 1 μm over an area of 7.25 mm x 5.44 mm (Fig. 4(a)). Then the doublet’s 
tilt was measured 5 times on each side. The average tilt was 0.093° with a standard deviation 
of 0.055°, indicating that the tilt is within tolerance. The decenter was measured using the 
integrated gage amplifier (IGA) of an ultra-precision lathe (Precitech). One lens of the doublet 
was centered on the spindle of the machine within 2 μm using the IGA (Fig. 4(b)). Then the 
runout of the second lens was measured. Any increase in runout corresponds to a decenter of 
half that value. This measurement was performed 5 times for each singlet. The average 
element decenter of the doublet was 6.1 μm with a standard deviation of 0.7 μm, again 
indicating that doublets can be built with acceptable deviations from nominal. 
 
Fig. 4. (a) Measuring tilt with a white light interferometer. The doublet’s average tilt was 
0.093° with a standard deviation of 0.055°. (b) Measuring decenter with an integrated gage 
amplifier. The doublet’s average decenter was 6.1 μm with a standard deviation of 0.7 μm. 
To measure the lateral, polychromatic resolution of the achromatic objective, an image of 
a hi-resolution target was relayed in reverse (placing the target in the image space of the 
achromatic objective). This setup causes the resolution to be limited by the achromatic 
objective’s image space NA = 0.14. For NA0.14, the Rayleigh resolution limit in white light 
is 2.40 μm, or 417 lp/mm, assuming a central wavelength of 550 nm. The hi-resolution target 
has features up to 645 lp/mm, so the target can be used to assess the smallest features the 
objective can resolve. The custom objective was set up to relay an image through an inverted 
microscope (Zeiss Axio Observer. A1, Zeiss) under white light trans-illumination. The object 
is placed in image space and a 40X, NA0.75 water immersion commercial objective (Zeiss) 
relays an image through the microscope to a CCD camera (Fig. 5(a)). The results are seen in 
Fig. 6(a) and Fig. 6(b). Because the custom objective is designed for a curved object 
(acceptable for imaging thick tissue), there is some field curvature and loss of performance at 
the edge of the FOV while imaging flat objects. The qualitative performance of the system 
was determined by locating the smallest resolvable feature, in this case group 8, element 5, 
which is 406 lp/mm. This is close to the theoretical diffraction limit, 417 lp/mm and is similar 
to the monochromatic performance of the objective described by Landau et al. [7]. 
The achromatic objective’s performance was further analyzed by measuring the Strehl 
ratio via the slanted-edge method of calculating the MTF [18]. An edge object was placed in 
front of the system in water immersion and the image was relayed with a 10X, NA0.3 Plan-
Neofluar objective (Zeiss) (Fig. 5(b)). A VariSpec liquid crystal tunable filter (LCTF) (CRi) 
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filtered the light to match the four design wavelengths (452 nm, 515 nm, 575 nm, and 623 
nm); the LCTF creates ~10 nm wide bands. For each waveband, sixteen edges were inspected, 
eight near the center and eight near 50% of the FOV. Figure 6(c) shows a set of four measured 
edges from one corner of a square on the resolution target; the remaining twelve edges were 
obtained from the square’s three other corners. An MTF curve was generated from each edge  
 
Fig. 5. Custom achromatic objective and commercial Zeiss objectives (a) relaying images in 
reverse and (b) relaying images as designed. 
 
Fig. 6. (a) The center of a hi-resolution 1951 USAF target illuminated with white light in 
transmission. The achromatic objective is operating in reverse, which means the resolution is 
limited by the image space NA = 0.14. (b) The region of interest outlined in (a). The smallest 
resolvable feature is group 8, element 5, which has a spatial frequency of 406 lp/mm. The 
theoretical diffraction limit is 417 lp/mm. (c) Set of four edges measured with the slanted edge 
method to determine the achromatic objective’s MTF and Strehl ratio. 
using the ISO 12233 standard [35]. The polychromatic MTF curve was created by averaging 
all 64 narrowband curves and is displayed in Fig. 7(a) compared to the diffraction limit. The 
Strehl ratio is 0.74 ± 0.05. 
The chromatic focal shifts of both the achromatic objective and the monochromatic 
objective described by Landau et al. [7] were measured using an MT25 precision length gauge 
(Heidenhain) to record the axial position of the stage. The LCTF was set to 450 nm and the 
best focal plane was found. The LCTF’s wavelength was increased by 20 nm and the new best 
focal plane was measured. This process was repeated until the wavelength reached 630 nm. 
The procedure was performed five times for each prototype objective, and the relative shifts 
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were averaged to find the chromatic focal shifts of the objectives, which are plotted in Fig. 
7(b) alongside the nominal shifts. The achromatic objective successfully brings two 
wavelengths of light into focus simultaneously while the monochromatic objective does not. 
Also, although the measured shifts were larger than expected, the achromatic objective’s 11.4 
μm maximum focal shift is smaller than the diffraction limited focal range of 22.0 μm. In 
contrast, the monochromatic objective’s 196.4 μm shift is almost an order of magnitude  
 
Fig. 7. (a) Polychromatic MTF of the achromatic objective. (b) Chromatic focal shifts of the 
achromatic objective and the monochromatic objective. 
greater than the diffraction limited focal range. To the best of our knowledge, we have built 
the first all plastic, achromatic microscope objective. 
5. Imaging results 
In vitro breast carcinoma cells from the 435S cell line were used for biological imaging with 
both prototype objectives. The cells were seeded on an 8-well microscope slide and stained 
with proflavine and cresyl violet. The proflavine, or 3,6-diaminoacridine hydrochloride 
(Sigma), was prepared as a 0.025% weight volume solution in 1X phosphate buffered saline 
(PBS) (Sigma), while the cresyl violet (Sigma) was prepared as a 0.05% weight volume 
solution in 1X PBS. Two hundred μL of each fluorescent dye solution were added to each 
well. The cells were stained for 5 minutes before the dye was removed. Each chamber was 
then washed with 500 μL of 1X PBS to remove excess dye. 
The breast carcinoma cells were imaged with the monochromatic and achromatic 
objectives separately through the Zeiss Imager.Z1, as well as with a Zeiss NA0.45 
commercial objective. Using a GFP filter set, proflavine was excited without exciting cresyl 
violet. The cells were brought into focus and an image was captured with the Imager’s 
monochrome camera. Without adjusting the position of the stage, we then imaged cresyl 
violet through a Texas Red filter set. The separate proflavine and cresyl violet images were 
recombined into single, pseudocolor images (Fig. 8). The Zeiss objective (Fig. 8, top row) 
demonstrates that proflavine preferentially stains nuclei while cresyl violet is concentrated in 
the cytoplasm. Both the monochromatic and achromatic objectives clearly showed proflavine 
staining the nucleus (Fig. 8, left column). However, the cytoplasm is blurry at the red 
wavelength when the cells are imaged with the monochromatic objective (Fig. 8, center). 
The cells were also imaged using structured illumination via the ApoTome attachment to 
the Imager.Z1 microscope using the procedure described above. Because the cells were 
already a monolayer, there was only a modest contrast improvement; when optically 
sectioning thick tissue, the reduction in background fluorescence will create a greater increase  
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 Fig. 8. Images of cells from the 435S breast carcinoma cell line stained with proflavine and 
cresyl violet. The commercial Zeiss objective and the prototype achromatic objective provide 
high resolution images for proflavine and cresyl violet simultaneously. In contrast, cresyl violet 
is out of focus with the monochromatic objective. 
in contrast. The commercial objective and achromatic objective again provided high quality 
images for both fluorescent dyes, while the monochromatic objective lost performance when 
imaging cresyl violet (Fig. 9). There is also a loss of intensity due to the structured 
illumination grid pattern being focused at a different depth. These effects are due to chromatic 
aberration; the focal planes for the excitation and emission wavelengths, which are conjugate 
for the commercial and achromatic objectives, are separated with the monochromatic 
objective. 
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Fig. 9. Structured illumination images of cells from the 435S breast carcinoma cell line stained 
with proflavine and cresyl violet. Structured illumination was created with the Zeiss ApoTome 
and the cells were imaged with (a) the NA0.45 Zeiss commercial objective, (b) the 
monochromatic objective, and (c) the achromatic objective. 
6. Conclusion 
An all-plastic, achromatic objective has been designed, toleranced, fabricated, and tested. The 
NA0.4 objective is an alternative to GRIN lenses, which suffer from significant chromatic 
aberration as well as performance loss across the FOV. Our objective is achromatized and 
maintains its performance across the designed 250 μm FOV, achieving a Strehl ratio of 0.74 ± 
0.05 while holding the optical surfaces’ clear apertures to 0.9 mm. Wide-field fluorescence 
imaging and optical sectioning via structured illumination are performed through the 
achromatic objective. Background reduction, via optical sectioning or another method, is 
critical when fluorescently imaging dense samples like breast tissue; without such methods, 
high levels of background create low contrast images. The achromatic objective permits using 
multiple dyes simultaneously, allowing staining which more closely mimics conventional 
histology. An ultra-slim achromatic objective can bring clinicians one step closer to 
performing high resolution, high contrast, in vivo optical biopsies to provide reliable cancer 
diagnoses. 
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